TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: ICSS pre‐ to post‐CAE change from baseline scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TCSS pre–post‐CAE change from baseline scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Schirmer’s score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean MSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Strengths and Difficulties Questionnaire (SDQ) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Growth of pathogenic microflora
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Serum levels of interleukin-1β (IL-1β), IL-6, IL-8, and IL-1 receptor antagonist
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bone resorption index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct diagnosis of upper UTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibiotic treatment recommendation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence in recommendation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EuroQol visual analogue scale (EQ-VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Knowledge about mental illness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Neonatal hospitalization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trace blood glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean viscosity values in the stomach
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean viscosity values in the upper small intestine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Intra‐subject variability of pH and buffer capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Acceptability rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: weight compensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in energy intake (EI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Rating Scale score for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean daily consumption of pregabalin and acetaminophen
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: level of patients’ satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adverse events related to adipose tissue extraction
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy to treat patients with structural FI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AIDA scores (healthier identity)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: occurrence of acute adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Total score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in negative symptoms of schizophrenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median percent reduction in focal seizure frequency/28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Seizure-free for ≥6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Seizure-free for ≥12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of death or severe disability or coma
Endpoint domain: Mortality/survival
Primary endpoint: Recovery of gastrointestinal functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction of stress responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum total 25‐hydroxyvitamin D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of overbite correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean cost for patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Constrictive physiology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence rate of psoriasis
Endpoint domain: Adverse events/effects
Primary endpoint: Total morphine consumption in 1st 48 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores at movement and rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gait ability in dual-task training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EMG of contractile amplitude of endurance phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of correct pelvic floor muscle contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: QCSA in the most symptomatic leg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 30sCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transition from thin to thick periodontal biotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Athens Insomnia Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: 5-year risk of fatal and nonfatal strokes
Endpoint domain: Mortality/survival
Primary endpoint: 30-day rate of stroke or death (perioperative complications)
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in UI symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in episodes and severity of UI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IIQ-7 score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: No improvement in symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: No improvement in quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Thirteen serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of correct pessary placements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urine leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: artefacts reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean rating of nasal deformity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal colonization by S. aureus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean number of S. aureus colonies in nasal swab cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean depth of biggest wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: maximum depth of biggest wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Administrative burden
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incentives for participation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 60-m sprint performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: autophagosome content (LC3-II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: autophagosome clearance marker (p62)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abundance of immatures of Ae. aegypti
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: shoulder pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Total Prosthesis Migration (MTPM) at 60 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower limb stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitions regarding domains of fertility problems
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvements in patient functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Prevention of cardiovascular disease cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevention of diabetes mellitus cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: BAT 18F-FDG uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in Bruce MET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first occurrence of 100% reduction in CH attacks per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with 50% or more reduction in weekly CH attacks at week 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of being large for gestational age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Neonatal hyperinsulinemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Percentage of women first authors
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of women senior authors
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average post-operative refractive cylinder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mental state score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-care skills scores
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Duration of postoperative hypocalcemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average pure tone hearing thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GHQ-12 score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SWLS score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: sleep efficiency index (SEI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: ratio of rapid eye movement sleep to total sleep (REM)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: arousal index (AI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Total skill scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signal-to-noise ratio (SNR) of middle cerebral arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BZRA prescription rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Composite surgical failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain score during dressing change
Endpoint domain: Adverse events/effects
Primary endpoint: Serum levels of TNF-α and IL-8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Success rate of tracheal tube passing through the lower pathway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Depression severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rACC thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of children having relapses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of VTE
Endpoint domain: Adverse events/effects
Primary endpoint: Proximal deep vein thrombosis and/or pulmonary embolism
Endpoint domain: Adverse events/effects
Primary endpoint: Predictive performance of RFC algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative Predictive Value (NPV) of cCTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity of cCTA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Long-term clinical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent UTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for VCUG
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: CAP exposure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of rehospitalization for acute decompensated HF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cumulative incidence of acute decompensation of HF and/or death
Endpoint domain: Mortality/survival
Primary endpoint: Patient loss to follow-up (PTLFU)
Endpoint domain: Mortality/survival
Primary endpoint: Quality-Adjusted Life Years (QALY) increases
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: peak torque of stimulated inferior limb extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: physical aspects of SF-36
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage weight loss at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Height standard deviation score (SDS) at NAH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PIPP values after heel lancing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fatigue strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean increase in sympathetic blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dermatomal spread of local anaesthetic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change of MAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median MAP AUB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in insomnia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tissue core rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean sampling procedural time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Survival rates at 2-year recall
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in QIDS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gains in muscular strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Curve progression criterion (≤5°)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Out-of-brace 2-year progression from initial deformity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fusion surgery rate
Endpoint domain: Adverse events/effects
Primary endpoint: hours in employment or education
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: peak VO2 (ml/kg/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infection rate at 30 days postoperative
Endpoint domain: Adverse events/effects
Primary endpoint: user experience
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: compliance with facial therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: coverage of careseeking to an appropriate provider for any iCCM illness
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: circulating lycopene
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: consultation for large-joint lower-limb OA/pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quality of Life (QOL) at end of RT
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Feeding tube use at end of RT
Endpoint domain: Adverse events/effects
Primary endpoint: Dysphagia (EAT-10 scores) at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: image interpretation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: confidence in abilities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ratio of interpretable cardiac PET images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypoglycemia cases
Endpoint domain: Adverse events/effects
Primary endpoint: pain VAS at passive movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: consumption of rescue drug (pethidine)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in SDS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to dialysis initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of participants initiating dialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of grade ≥2 Peripheral Sensory Neuropathy (PSN)
Endpoint domain: Adverse events/effects
Primary endpoint: Oral health improvement after therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment worthiness (cost and efforts)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to self‐performed periodontal infection control
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Risk of PVT after splenectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Depression/anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-Traumatic Stress Disorder symptom categories
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of severe gastrointestinal intolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Progression at metastatic sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median total sunitinib treatment duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constipation Severity Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bristol Stool Chart score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: need for additional maneuvers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of mammograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Response rates to preoperative questionnaire
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: anti-Factor Xa activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of leakage from the catheter insertion site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Decreased appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WST level I-II grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum substance P level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Autonomous motivation for physical activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Controlled motivation for physical activity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sedentary self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Development of Grade 3 mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unplanned treatment breaks
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hospitalization of patients
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: low back pain unpleasantness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting and squeeze pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes